UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035076
Receipt number R000039168
Scientific Title Can I predict the effectiveness of medication therapy and risk of recurrence with preoperative examinations in GH-producing pituitary adenoma?
Date of disclosure of the study information 2018/12/01
Last modified on 2021/11/01 15:22:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Can I predict the effectiveness of medication therapy and risk of recurrence with preoperative examinations in GH-producing pituitary adenoma?

Acronym

Can I predict the effectiveness of medication therapy and risk of recurrence with preoperative examinations in GH-producing pituitary adenoma?

Scientific Title

Can I predict the effectiveness of medication therapy and risk of recurrence with preoperative examinations in GH-producing pituitary adenoma?

Scientific Title:Acronym

Can I predict the effectiveness of medication therapy and risk of recurrence with preoperative examinations in GH-producing pituitary adenoma?

Region

Japan


Condition

Condition

acromegaly

Classification by specialty

Endocrinology and Metabolism Endocrine surgery Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Can pre-operative evaluation predict the post-operative prognosis and effectiveness of medication therapy in acromegaly?

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Exploring pre-operative marker which can predict post-operative prognosis

Key secondary outcomes

1. relationship between diagnostic imaging study and hormonal findings

2. exploring effective factor of medication therapy


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with acromegaly based on `guideline of diagnosis and treatment with acromegaly` published by japan endocrine society.

Key exclusion criteria

nothing

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Masakatsu
Middle name
Last name Sone

Organization

Graduate school of medicine and faculty of medicine Kyoto university

Division name

Department of diabetes, endocrinology and nutrition

Zip code

6068501

Address

54 kawara-cho, shougoin, sakyou-ku, Kyoto city, Kyoto, Japan

TEL

075-751-3560

Email

kyotorinsho@gmail.com


Public contact

Name of contact person

1st name Sachiko
Middle name
Last name Kawashima

Organization

Kyoto university hospital

Division name

Department of diabetes, endocrinology and nutrition

Zip code

6068501

Address

54 kawara-cho, shougoin, sakyou-ku, Kyoto city, Kyoto, Japan

TEL

075-751-3560

Homepage URL


Email

kyotorinsho@gmail.com


Sponsor or person

Institute

Graduate school of medicine and faculty of medicine Kyoto university

Institute

Department

Personal name



Funding Source

Organization

Graduate school of medicine and faculty of medicine Kyoto university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto university graduate school and faculty of medicine, Kyoto university hospital Ethics committe

Address

54 kawara-cho, shougoin, sakyou-ku, Kyoto city, Kyoto, Japan

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 11 Month 30 Day

Date of IRB

2018 Year 12 Month 01 Day

Anticipated trial start date

2018 Year 12 Month 03 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry

2021 Year 03 Month 31 Day

Date trial data considered complete

2021 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

retrospective cross sectional study


Management information

Registered date

2018 Year 11 Month 30 Day

Last modified on

2021 Year 11 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039168


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name